
Neurones SA
PAR:NRO

Intrinsic Value
The intrinsic value of one
NRO
stock under the Base Case scenario is
41.41
EUR.
Compared to the current market price of 48.45 EUR,
Neurones SA
is
Overvalued by 15%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Neurones SA
Fundamental Analysis


Revenue & Expenses Breakdown
Neurones SA
Balance Sheet Decomposition
Neurones SA
Current Assets | 546.3m |
Cash & Short-Term Investments | 264.2m |
Receivables | 267m |
Other Current Assets | 15.1m |
Non-Current Assets | 133.1m |
Long-Term Investments | 10.9m |
PP&E | 60.2m |
Intangibles | 55.6m |
Other Non-Current Assets | 6.4m |
Free Cash Flow Analysis
Neurones SA
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
Neurones SA
Revenue
|
774.9m
EUR
|
Cost of Revenue
|
-722k
EUR
|
Gross Profit
|
774.2m
EUR
|
Operating Expenses
|
-700.6m
EUR
|
Operating Income
|
73.6m
EUR
|
Other Expenses
|
-25.1m
EUR
|
Net Income
|
48.5m
EUR
|
NRO Profitability Score
Profitability Due Diligence
Neurones SA's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Score
Neurones SA's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
NRO Solvency Score
Solvency Due Diligence
Neurones SA's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

Score
Neurones SA's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NRO Price Targets Summary
Neurones SA
According to Wall Street analysts, the average 1-year price target for
NRO
is 61.2 EUR
with a low forecast of 60.6 EUR and a high forecast of 63 EUR.
Dividends
Current shareholder yield for NRO is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
NRO
stock under the Base Case scenario is
41.41
EUR.
Compared to the current market price of 48.45 EUR,
Neurones SA
is
Overvalued by 15%.